INS and hepatocellular carcinoma: Our in vitro experiments have shown that limiting AKR1D1 expression and activity regulates fundamental metabolic processes within human hepatoma cells that govern hepatic insulin sensitivity, lipid accumulation and carbohydrate metabolism.